Product
Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)
1 clinical trial
2 indications
Indication
Influenza ImmunizationIndication
Healthy Control ParticipantsClinical trial
Immunogenicity and Safety of a High-Dose Quadrivalent Influenza Vaccine Administered by the Intramuscular Route in Subjects 60 Years of Age and OlderStatus: Completed, Estimated PCD: 2020-01-09